Skyscape Web Viewer : Evidenced-Based Medicine Guidelines (EBMG) : Main Index

View All
Antibodies, Viral
Antibodies
Antibody
Anti-centromere antibodies
Anticholesteremic Agents Efficacy and Safety of Cholesterol Lowering by Statins Statins and Fibrates for Preventing Melanoma Statins for the Primary Prevention of Cardiovascular Disease
Anticholinergic agents
Anticholinergic drugs
Anticholinergic drugs
Anticholinergic syndrome Drugs Commonly Causing Poisonings Neuroleptic Malignant Syndrome (Nms) Treatment of Poisoning
Anticholinergic syndrome, central
Anticholinergics
Anticholinergics
Anticholinergics
Anticholinergic therapy
Anti-cholinesterases
Anticoagulants
Anticoagulants
Anticoagulants
Anticoagulant therapy
Anticoagulant therapy
Anticoagulant therapy
Anticoagulant
Anticoagulation, oral
Anticoagulation therapy Increased Pulmonary Blood Pressure: Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Interventions for Haemolytic Uraemic Syndrome (Hus) and Thrombotic Thrombocytopenic Purpura (TTP) Low-Intensity Warfarin for Long-Term Prevention of Venous Thromboembolism Selecting Anticoagulant Therapy in Atrial Fibrillation Subconjunctival Haemorrhage (Suggillation) Treatment of Distal Deep Vein Thrombosis Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Anticoagulation treatment Antiplatelet Therapy for Patients with Non-Valvular Atrial Fibrillation Indications for and Implementation of Anticoagulant Therapy in Atrial Fibrillation Treatment of Distal Deep Vein Thrombosis
Anticoagulation
Anticoagulation
Anticoagulation
Anticonvulsants
Anticonvulsants